-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Abidor Hydrochloride Capsules Awarded the Title of “China’s Most Innovative Pharmaceutical Formulation”
Category:
发布时间：2019-10-29
【概要描述】
From October 11 to 13, the 13th China Pharmaceutical Preparations Conference 2019 was grandly held in Yantai, Shandong Province. Concurrent with the conference, two prestigious rankings were unveiled: “China’s Most Promising Innovative Technology-Based Pharmaceutical Enterprises of 2019” and “China’s Most Innovative Pharmaceutical Formulation Products of 2019.” The company’s broad-spectrum antiviral drug, Ainuoda® Arbidol Capsules, was honored as “China’s Most Innovative Pharmaceutical Formulation Product of 2019.”
From October 11 to 13, the 13th China Pharmaceutical Preparations Conference 2019 was grandly held in Yantai, Shandong Province. Concurrent with the conference, two prestigious rankings were unveiled: the “2019 China’s Most Promising Innovative Science and Technology–Driven Pharmaceutical Enterprises” and the “2019 China’s Most Innovative Pharmaceutical Preparations.” The company’s broad-spectrum antiviral drug, Ainuoda® Arbidol Capsules, was honored as a “2019 China’s Most Innovative Pharmaceutical Preparation.”
This conference is hosted by the Chinese Pharmaceutical Association and co-organized by the Pharmaceutical Preparations Professional Committee of the Chinese Pharmaceutical Association, the China Chapter of the International Society for Controlled Release, and other organizations, giving it considerable authority and influence within the industry. The award bestowed upon Ainuoda® is a well-deserved recognition of the company’s innovative capabilities and R&D excellence, and it is the culmination of the dedicated efforts and hard work of the company’s R&D team.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091